97130 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
E. COLI FIMH MUTANTS AND USES THEREOF
#2METHOD AND REAGENTS FOR ULTRASENSITIVE IMMUNOASSAY
#3ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE
#4PATHOGEN BINDING PROTEINS
#5HMGB1 PROTEIN DERIVATIVES FOR THE REMOVAL OF BIOFILMS
#6FIMH INHIBITING COMPOSITIONS AND METHODS OF USE THEREOF
#7VHH ANTIBODIES TARGETING FIMH AND METHODS OF USING THE SAME
#8ANTI-SHIGA MONOCLONAL ANTIBODY AND USES THEREOF
#9ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE
#10ANTIBODY COMPOSITIONS FOR DISRUPTING BIOFILMS
#11MDR E. COLI IMMUNOGEN
#12COMPOSITION CONTAINING MONOCLONAL ANTIBODY
#13METHODS AND COMPOSITIONS FOR PREVENTING INFECTION
#14ANTI-ETEC ADHESIN PROTEIN ANTIBODIES AND METHODS OF USE
#15FimH Mutant, Compositions Therewith And Use Thereof
#16METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#17SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#18MONOCLONAL ANTIBODY AND USES THEREOF FOR THE TREATMENT AND DIAGNOSIS OF MULTIDRUG-RESISTANT PATHOGENIC BACTERIAL INFECTIONS
#19ANTI-CfaE ANTIBODIES AND METHODS OF USE
#20Peptides and antibodies for the removal of biofilms
#21METHOD AND KIT FOR DETECTING PRESENCE AND/OR AMOUNT OF BACTERIA IN FOOD/DRINK SAMPLE, ENVIRONMENTAL SAMPLE, OR BIOLOGICAL SAMPLE
#22Anti-ETEC adhesin protein antibodies and methods of use
#23COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY
#24ENGINEERED BINDING PROTEINS FOR RECOGNITION OF BACTERIA
#25DUAL TARGETING
#26MDR immunogen
#27Compositions and methods for the removal of biofilms
#28Antigen Binding Proteins to Class 5 ETEC Adhesins
#29TREATING OR PREVENTING TRAVELERS DIARRHEA
#30CROSS-REACTIVE ANTIBODIES AND USES THEREOF
#31Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
#32FimH mutant, compositions therewith and use thereof
#33TOOLS AND METHODS TO DETECT AND ISOLATE COLIBACTIN PRODUCING BACTERIA
#34Compositions and methods for the treatment of immunodeficiency
#35Antibody compositions for disrupting biofilms
#36ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF
#37Eradication of bacterial biofilm using anti-amyloid monoclonal antibodies
#38Compositions and methods for the removal of biofilms
#39E. COLI FIMH MUTANTS AND USES THEREOF
#40METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES
#41PATHOGEN BINDING PROTEINS
#42Anti-ETEC adhesin protein antibodies and methods of use
#43Anti-CfaE antibodies and methods of use
#44HMGB1 PROTEIN DERIVATIVES FOR THE REMOVAL OF BIOFILMS
#45Compositions and methods for reducing bacterial aggregation
#46Methods for diagnosis and treatment of type 1 diabetes
#47Peptides and antibodies for the removal of biofilms
#48Antibody compositions for disrupting biofilms
#49Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM
#50MDR immunogen
#51SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#52METHOD FOR DETECTING VEROTOXIN
#53Compositions and methods for the treatment of immunodeficiency
#54Eradication of bacterial biofilm using anti-amyloid monoclonal antibodies
#55DUAL TARGETING
#56Antibacterial antibody and use thereof
#57COMPOSITIONS AND METHODS FOR TREATMENT IN BROAD-SPECTRUM, UNDIFFERENTIATED OR MIXED CLINICAL APPLICATIONS
#58Compositions and methods of enhancing immune responses to enteric pathogens
#59GENERATION OF HEAVY-CHAIN ONLY ANTIBODIES IN TRANSGENIC ANIMALS
#60METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IGM
#61Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
#62OB-fold used as scaffold for engineering new specific binders
#63Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease
#64Means and methods for oral protein delivery
#65Compositions and methods for the removal of biofilms
#66Recombinant gram negative bacteria and methods of generating and utilizing same
#67Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
#68Compositions and methods of enhancing immune responses to enteric pathogens
#69Anti-LPS Enriched Immunoglobulin Preparation for Use in the Treatment and/or Prophylaxis of a Pathologic Disorder
#70Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
#71MDR specific antibody
#72Adhesin as immunogen against enterotoxigenic
#73Combined enteropathogen recombinant construct
#74Peptides and antibodies for the removal of biofilms
#75Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
#76Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#77PURIFICATION OF FKPA AND USES THEREOF FOR PRODUCING RECOMBINANT POLYPEPTIDES
#78IgG, IgA and IgM antibody preparations, method of making and method of use in treatment
#79PROTEINS AND NUCLEIC ACIDS FROM MENINGITIS/SEPSIS-ASSOCIATED ESCHERICHIA COLI
#80Compositions and methods for the treatment of immunodeficiency
#81Methods of making heavy chain only antibodies using transgenic animals
#82CS21 AND LNGA PROTEIN VACCINES
#83Compositions and methods for treatment and prevention of uropathogenic infection
#84Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#85Sensor systems for target ligands and uses thereof
#86DUAL TARGETING
#87Compositions and methods for the treatment of immunodeficiency
#88ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE
#89Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
#90Method for purification of monoclonal antibodies
#91Combined enteropathogen recombinant construct
#92Monoclonal antibody against muramyl peptides
#93Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
#94Affinity proteins and uses thereof
#95OB-fold used as scaffold for engineering new specific binders
#96specific antibodies
#97Antibody molecule-drug conjugates and uses thereof
#98MDR specific antibody
#99Antibody preparations
#100Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#101Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
#102Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
#103Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
#104Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders
#105Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#106Molecular constructs for treating central nervous system diseases
#107Molecular constructs for treating infectious diseases
#108Peptide core-based multi-arm linkers for treating infectious diseases
#109BACTERIAL INFLUENCE OF HOST FEEDING AND EMOTION VIA CLPB PROTEIN MIMICRY OF A-MSH
#110Antibody possessing an affinity for epithelial secretory and nervous tissue, as well as tumour tissue derived from these tissues as well as the use thereof
#111Hypericin albumin nanoparticle-serum antibody complex and preperation method and application thereof
#112Generation of heavy-chain only antibodies in transgenic animals
#113Proteins and nucleic acids from meningitis/sepsis-associated
#114Methods and compositions based on Shiga toxin type 2 protein
#115Vaccine
#116AN ISOLATED IMMUNOGENIC BACTERIAL ANTIGEN AND ITS USE IN THE PREVENTION AND TREATMENT OF INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA
#117Chimeras of lumazine synthase and beta subunit of ABtoxins
#118Compositions and methods for the treatment of immunodeficiency
#119Compositions and methods for the treatment of immunodeficiency
#120Immunogenic compositions containing H7 flagella and methods of use thereof
#121Compositions and methods of enhancing immune responses to enteric pathogens
#122Vaccine for preventing porcine edema disease
#123ECF-BINDING AGENTS AND USES THEREOF
#124Monoclonal antibody against muramyl peptides
#125MDR specific antibody
#126Adhesin as immunogen against enterotoxigenic
#127Protective anti-ETEC antibody
#128Compositions and Methods for the Removal of Biofilms
#129Antibody preparations
#130BACTERIALLY FORMED MICROCIN S, A NEW ANTIMICROBIAL PEPTIDE, EFFECTIVE AGAINST PATHOGENIC MICROORGANISMS, E.G. ENTEROHEMORRHAGIC ESCHERICHIA COLI (EHEC)
#131Compositions and methods for bacterial and genetically modified microorganism production of chondroitin
#132Biomarkers for detecting the presence of bacteria
#133Immunogenic heat stable enterotoxin
#134Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
#135HUMANIZED MONOCLONAL ANTIBODIES THAT PROTECT AGAINST SHIGA TOXIN INDUCED DISEASE
#136Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
#137Method of preparing antigen for acquiring anti-hydrophobic peptide antibody
#138Compositions against bacterial toxins
#139Binding molecules
#140Binding molecules
#141METHODS AND COMPOSITIONS BASED ON SHIGA TOXIN TYPE 1 PROTEIN
#142Process for preparing an immunoglobulin composition
#143Antibody preparations
#144Egg White Antibodies for Prevention and Treatment of Specific Localized Intestinal Infections and Diseases Associated with a Pathogenic Organism or Molecule
#145Products comprising inactivated yeasts or moulds and active VHH-type antibodies
#146ENTEROTOXIGENIC E. COLI FUSION PROTEIN VACCINES
#147Methods for producing cytokine receptor ZALPHA11
#148METHODS, COMPOSITIONS, AND KITS FOR TREATING SHIGA TOXIN ASSOCIATED CONDITIONS
#149Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
#150Anti-LPS enriched immunoglobulin preparations for the treatment and/or prophylaxis of a pathologic disorder
#151Methods and compositions for treating and preventing Shiga toxin-producing infection
#152Bacterial virulence factors and uses thereof
#153Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#154Methods and compositions based on shiga toxin type 2 protein
#155Immunogenic heat stable enterotoxin
#156Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders
#157Compositions and methods for bacterial production of chondroitin
#158Compositions and methods for the removal of biofilms
#159Method of binding bacterial lipopolysaccharides to a solid phase
#160Methods for detecting modulators of cytokine receptor zalpha11
#161Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides
#162IMMUNOGEN SELECTION DIRECTED IN IMMUNOGLOBULIN PACKAGES IN PLASMA AND COLOSTRUM AND METHOD OF MAKING AND USING SAME
#163BINDING MOLECULES
#164PROPHYLACTIC/THERAPEUTIC AGENT FOR INFECTIOUS DISEASE
#165Immunogenic compositions containing H7 flagella and methods of use thereof
#166Pathogenic associated protein
#167Anti-adhesin based passive immunoprophylactic
#168Antibodies to cytokine receptor zalpha11
#169Binding molecules
#170Binding molecules
#171HUMANIZED MONOCLONAL ANTIBODIES THAT PROTECT AGAINST SHIGA TOXIN INDUCED DISEASE
#172Antibodies for preventing and treating attaching and effacing (AEEC) associated diseases
#173HUMANIZED MONOCLONAL ANTIBODIES THAT PROTECT AGAINST SHIGA TOXIN INDUCED DISEASE
#174AFFINITY PURIFIED HUMAN POLYCLONAL ANTIBODIES AND METHODS OF MAKING AND USING THEM
#175OB-FOLD USED AS SCAFFOLD FOR ENGINEERING NEW SPECIFIC BINDERS
#176Detection and therapy of bacterial infection caused by
#177USE OF ADHESION MOLECULES AS BOND STRESS-ENHANCED NANOSCALE BINDING SWITCHES
#178GENERATION OF HEAVY-CHAIN ONLY ANTIBODIES IN TRANSGENIC ANIMALS
#179Method of reducing the viscosity of mucus
#180Binding molecules
#181Pharmaceutical compositions comprising bioelastomer fusion proteins
#182METHODS, COMPOSITIONS, AND KITS FOR TREATING SHIGA TOXIN ASSOCIATED CONDITIONS
#183Calf biologic anti-scour supplement (CBAS)
#184Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#185Antibodies for preventing and treating attaching and effacing (AEEC) associated diseases
#186Human neutralizing antibodies against hemolytic uremic syndrome
#187Proteins and nucleic acids from meningitis/sepsis-associated
#188Humanized neutralizing antibodies against hemolytic uremic syndrome
#189Humanized neutralizing antibodies against hemolytic uremic syndrome
#190Methods and compositions based on Shiga toxin type 1 protein
#191Host Receptor for Pathogenic Bacteria
#192Host receptor for pathogenic bacteria
#193METHODS FOR DETECTING MODULATORS OF CYTOKINE RECEPTOR ZALPHA11
#194Method for detecting a host receptor for pathogenic bacteria
#195METHODS FOR DETECTING MODULATORS OF CYTOKINE RECEPTOR ZALPHA11
#196Antibodies to cytokine receptor zalpha11
#197CYTOKINE RECEPTOR ZALPHA11
#198Humanized monoclonal antibodies that protect against shiga toxin induced disease
#199Composition and method for the treatment and prevention of enteric bacterial infections
#200Bacterial virulence factors and uses thereof
#201Antimicrobial activity of antibodies producing reactive oxygen species
#202Humanized monoclonal antibodies that protect against shiga toxin induced disease
#203Cross-beta structures on microbial organisms
#204Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
#205Pathogenic associated protein
#206Anti-adhesin based passive immunoprophlactic
#207Adhesin as immunogen against enterotoxigenic
#208Method of reducing complement - mediated disruption of cells
#209Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
#210Heteropolymer complexes and methods for their use
#211Monoclonal antibody which agglutinates having the CS4-CFA/I family protein
#212Methods of using cytokine receptor zalpha11 to detect its ligands
#213High affinity monoclonal antibodies for detection of shiga toxin 2
#214High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2)